Chlorhexidine Gluconate, 0.12% Oral Rinse Solution
NDC Package 81033-512-50
Package Information
Chlorhexidine Gluconate, 0.12% Oral Rinse Solution (chlorhexidine gluconate, 0.12% oral rinse) solution is a medication used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. This formulation utilizes a solution delivery system. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-512 and is authorized under FDA application ANDA075561.
Identification & Billing
- RxCUI: 834127 - chlorhexidine gluconate 0.12 % Oral Rinse
- RxCUI: 834127 - chlorhexidine gluconate 1.2 MG/ML Mouthwash
- RxCUI: 834127 - chlorhexidine gluconate 0.12 % Mouthwash
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81033 - Kesin Pharma Corporation
- 81033-512 - Chlorhexidine Gluconate, 0.12% Oral Rinse Solution
- 81033-512-50 - 100 CUP, UNIT-DOSE in 1 CARTON / 15 mL in 1 CUP, UNIT-DOSE (81033-512-15)
- 81033-512 - Chlorhexidine Gluconate, 0.12% Oral Rinse Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81033-512-50 identifies a specific commercial package of 100 cup, unit-dose in 1 carton / 15 ml in 1 cup, unit-dose (81033-512-15) of Chlorhexidine Gluconate, 0.12% Oral Rinse Solution, a human prescription drug labeled by Kesin Pharma Corporation. This solution is formulated for dental use and contains chlorhexidine gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kesin Pharma Corporation on August 15, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria in the mouth, helping to reduce swelling and redness of the gums and bleeding when you brush.
How is this Kesin Pharma Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033051250. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.